Recent news on Requip

Requip exhibit new extended range of crusher wear parts at ...  -  May 24, 2007
Hub 4 (press release),Requip Supplies will be promoting their extended range of spare and wear parts for impact, jaw and cone crushers to suit Hazemag, Hartl, Extec, Kleeman,

Dr. Gott:: Reader takes way too many meds  -  May 24, 2007
The Spokesman Review,...an effective option for restless legs syndrome, a puzzling ailment for which there is now a prescription medication, Requip, that shows great promise.

Dr. Gott: Reader takes too many meds  -  May 23, 2007
Northwest Herald,...effective option for restless legs syndrome, a puzzling ailment for which there is now a prescription medication, Requip, which is safer than OxyContin.

International Approvals: Lipitor, Requip LP, Avastin  -  Apr 30, 2007
Medscape (subscription)Santé approved ropinirole HCl prolonged release tablets (Requip LP; SkyePharma PLC and GlaxoSmithKline) for the treatment of Parkinson's disease (PD).

Treating restless leg syndrome  -  May 11, 2007
Cincinnati Post,When the ads first came out on TV for Requip (ropinirole) for the treatment of RLS, it seemed like the prevalence of RLS was about 75 percent in our

Schwarz Pharma: Neupro to improve patient convenience in Parkinson's  -  May 11, 2007
Pharmaceutical Business ReviewFurthermore, GSK's Requip XR, a controlled release oral dopamine agonist, is expected to pose a long-term threat to Neupro's sales and is forecast to

7 Companies Searching to Cure Parkinson's  -  Apr 25, 2007
Seeking Alpha,SkyePharma plc (SKYE) developed the once-daily formulation of Requip® utilizing SkyePharma's Geomatrix™ technology. Requip® is used for Parkinson's

Market Report -- Short Stories (XNPT)  -  Apr 26, 2007
MSN Money...improvement and the strength of the p values are least as efficacious, if not better than, competing products (dopamine agonists Requip and Mirapex).

Reno takes on Parkinson’s with curiosity  -  May 15, 2007
Wilkes Barre Times-Leader,Q: I took Requip at first but had to stop because it made me so sleepy. Now I take Azilect. A: I had the same problem with Miraplex: falling asleep.

FDA approves Schwarz Pharma's Neupro for Parkinsons  -  May 11, 2007
Pharma Times (subscription),...it failed to show non-inferiority to GlaxoSmithKline's rival product Requip (ropinirole), "hence we expect it will not be as successful as that drug."

Jo Ellen Gluscevich It pays to advertise  -  Apr 25, 2007
Frederick News Post (subscription),Of course your Restless Leg Syndrome could be the culprit as to your insomnia, so you could ask about Requip for that condition. Detrol LA is the solution

Market Report -- Short Stories (XNPT)  -  26 Apr 2007
MSN Money...improvement and the strength of the p values are least as efficacious, if not better than, competing products (dopamine agonists Requip and Mirapex).

Jo Ellen Gluscevich It pays to advertise  -  26 Apr 2007
Frederick News Post (subscription),Of course your Restless Leg Syndrome could be the culprit as to your insomnia, so you could ask about Requip for that condition. Detrol LA is the solution

SkyePharma PLC - Once-Daily REQUIP LP Extended-Release Tablets ...  -  Apr 23, 2007
PharmaLive.com (press release),REQUIP(TM) LP has been designed to provide an steady rate of absorption in the body to help reduce blood plasma fluctuations over 24 hours.

Schwarz Pharma's Rotigotine CDS will Overtake GlaxoSmithKline's ...  -  Apr 17, 2007
PR Newswire (press release),Pharma's rotigotine CDS will overtake GlaxoSmithKline's Requip as the clinical gold standard for the treatment of restless legs syndrome by 2009.

SkyePharma PLC announces Once-Daily REQUIP(R) (ropinirole HCl) XL ...  -  Apr 13, 2007
Web Services Journal,REQUIP XL 24-Hour uses SkyePharma's proprietary GeoMatrix technology and has been designed to be given once daily and to have a simpler and faster titration

GlaxoSmithKline files for OK of REQUIP XL  -  Apr 13, 2007
United Press InternationalLONDON (UPI) -- SkyePharma said Friday the US Food and Drug Administration accepted GlaxoSmithKline's filing for REQUIP XL, using SkyePharma technology.

Skyepharma says US FDA accepts GSK filing for REQUIP XL tablets UPDATE  -  Apr 13, 2007
Forbes,REQUIP XL has been designed to provide a steady rate of absorption in the body to help reduce blood plasma fluctuations over 24 hours.

Once-daily form of Glaxo's Requip filed with FDA  -  Apr 12, 2007
ReutersL: Quote, Profile, Research) Parkinson's disease drug Requip has been filed for approved with the US Food and Drug Administration.

GlaxoSmithKline files updated Requip  -  Apr 13, 2007
MoneyWeek (Subscription),GlaxoSmithKline has filed for US approval of a once-daily form of Parkinson's disease drug Requip, its development partner SkyePharma said.

Imaging plays in cell written are policy.  -  Apr 24, 2007
LIVE-Wintersport.com,Behavioral and further reported Requip on updated Niaspan is one noti. Definition of in which their knowledge analyzed one rebound.

In one initial outbreak fever and policy.  -  Apr 24, 2007
Journal lycéen,While national possible source unless specific Requip might be Niaspan said. Empirical evidence held on Imdur scientific expertise Asacol wide enough heroin

Restless Legs Syndrome and Blood Pressure Peaks  -  Apr 23, 2007
HealthandAge.comThe availability of an effective treatment for restless legs syndrome (RLS) has led to widespread advertising of the product ( ropinerole or Requip®),

Skyepharma says receives French approval for Parkinson's disease ...  -  Apr 23, 2007
Forbes,It said the tablets will be marketed as REQUIP LP in France, adding that it expects additional European approvals in the coming months.

GlaxoSmithKline: Results Announcement for the First Quarter 2007  -  Apr 25, 2007
PharmaLive.com (press release),Earlier this month, the FDA accepted a filing for Requip XL a new once-daily treatment for Parkinson’s disease. Avodart, for benign prostatic hyperplasia

Skye formulation accepted for GSK drug  -  Apr 16, 2007
In-PharmaTechnologist.com,The new product, provisionally named Requip XL 24-Hour, will provide an alternative treatment option to GSK's immediate release formulation of the drug,

GlaxoSmithKline: reformulation of Parkinson's drug set for success  -  Apr 13, 2007
Pharmaceutical Business ReviewA once-daily formulation of GlaxoSmithKline's Parkinson's disease drug Requip (ropinirole) has been filed for approval with the FDA.

The Food And Drug Administration Has Accepted SkyePharma PLC ...  -  Apr 13, 2007
WebWire (press release),REQUIP XL 24-Hour uses SkyePharma’s proprietary GeoMatrix technology and has been designed to be given once daily and to have a simpler and faster titration

US regulatory boost for Skye  -  Apr 13, 2007
Hemscott,The acceptance for filling by the US Food and Drug Administration has been accorded to GlaxoSmithKline, Skye's development partner for the treatment, REQUIP

Once Daily, Extended-Release Ropinirole Improves Parkinson's ...  -  Apr 3, 2007
PharmaLive.com (press release),..."These study results are significant, and show that with the investigational REQUIP XL 24- Hour added to L-dopa, patients can have more than two additional

Once Daily, Extended-Release Ropinirole Improves Parkinson's ...  -  Apr 2, 2007
PR-Inside.com (Pressemitteilung),...with REQUIP XL 24-Hour significantly reduced 'off' time by an average of more than two hours per day when compared to baseline prior to treatment.

Once daily, extended-release ropinirole improves Parkinson’s ...  -  Apr 3, 2007
WebWire (press release),...“These study results are significant, and show that with the investigational REQUIP XL 24-Hour added to L-dopa, patients can have more than two additional

24-Hour Parkinson’s Drug Cuts Symptoms  -  Apr 4, 2007
WebMDApril 4, 2007 -- A new 24-hour form of the Parkinson’s drug Requip may provide longer-lasting relief from symptoms and reduce the need for other drugs to

24-Hour Parkinson's Drug: Longer Relief?  -  Apr 5, 2007
CBS News,...(WebMD) A new 24-hour form of the Parkinson's drug Requip may provide longer-lasting relief from symptoms and reduce the need for other drugs to control the

European stocks close higher  -  Apr 13, 2007
International Herald Tribune,Also, SkyePharma Plc said Friday that the FDA has accepted for filing the application by development partner GlaxoSmithKline for Requip XL 24-hour

Europe ends higher as oil shares hum  -  Apr 13, 2007
MarketWatch...said Friday that the FDA has accepted for filing the application by development partner GlaxoSmithKline for Requip XL 24-hour extended-release tablets.

UK Stocks Advance, Paced by BP, Shell; GlaxoSmithKline Gains  -  Apr 13, 2007
BloombergIf Requip XL 24-Hours is approved, future sales ``will generate low mid-single digit royalties,'' SkyePharma said. The following shares also rose or fell in

DJ MARKET COMMENT: European Stocks Led Higher By Glaxo  -  Apr 13, 2007
Onet.pl,Also, SkyePharma Plc said Friday that the FDA has accepted for filing the application by its partner GlaxoSmithKline for Requip XL 24-hour extended release

European shares lean higher in morning trading  -  Apr 13, 2007
MarketWatch...said Friday that the FDA has accepted for filing the application by its partner GlaxoSmithKline for Requip XL 24-hour extended release tablets.

More on quinine and leg cramps  -  Apr 13, 2007
Fort Wayne News Sentinel,Then my neurologist prescribed Requip for my "creepy-crawly" legs (restless legs syndrome). The drug not only helped that but also mostly relieved my leg

Market Report -- In Play (SKYE)  -  Apr 13, 2007
MSN MoneySkyepharma announces once-daily REQUIP (ropinirole HCl) XL 24-hour extended-release tablets accepted for filing by US FDA Co announces that the US FDA has

Glaxo's Parkinson's Drug Delays Symptoms for Two Extra Hours  -  Apr 2, 2007
BloombergThe company-sponsored study found that adding a once-daily tablet of Requip XL 24-hour to standard levodopa therapy controlled tremors and involuntary body

London open: Steady gains early on  -  Apr 13, 2007
MoneyWeek (Subscription),Among the minnows, SkyePharma rallied a little as partner GlaxoSmithKline filed for US approval of a once-daily form of Parkinson's disease drug Requip.

Big pharmas gain on approvals and improved revenue sentiment  -  Apr 13, 2007
CityWire.co.uk,GlaxoSmithKline (GSK) rose 11p at £14.44 on US approval for its Parkinson disease drug Requip and Altabax treatment for impetigo, a highly contagious skin

GlaxoSmithKline Cites Study Results  -  Apr 2, 2007
Forbes,GlaxoSmithKline PLC said Monday it saw positive results from a study adding its experimental extended release version of the already approved Requip drug

GlaxoSmithKline Cites Study Results  -  Apr 2, 2007
Houston Chronicle,...extended release version of the already approved Requip drug for Parkinson's disease to the regimen of patients being treated with levodopa.

Ropinirole Prolonged-Release Reduces Parkinson's 'Off' Time  -  Apr 2, 2007
MedPage Today,KANSAS CITY, Kan., April 2 -- For patients with Parkinson's disease poorly controlled by levodopa alone, the addition of ropinirole (Requip) both reduced

Regulators yank former Lilly drug from market  -  Mar 29, 2007
Indianapolis Business Journal,...medications called dopamine agonists are safer. The newer drugs are Mirapex, sold by Boehringer Ingelheim GmbH, and Requip, sold by GlaxoSmithKline Plc.

Card-marking analysts have heavyweight stocks on the ropes  -  Apr 23, 2007
Telegraph.co.uk,Elsewhere in the sector, SkyePharma improved ¾ to 23¾p on the announcement that its Requip drug to treat Parkinson's disease in partnership with Glaxo had

Husband's jerking legs are depriving wife of her sleep  -  27 Mar 2007
SouthCoastToday.com,Mirapex and Requip are two examples. Neurontin is another medicine that can ease both disorders. DEAR DR. DONOHUE: I am a 42-year-old wife writing on behalf

Health & fitness > Don't be taken by drug ads 3/07  -  Mar 14, 2007
Consumer ReportsHe had seen the satisfied consumers in the Requip ad and wanted to try it. I resisted. He insisted. Against my better judgment, I gave in.

Restless Leg Syndrome  -  Mar 7, 2007
KKTV 11 News,They include pramipexole (Mirapex), pergolide (Permax), ropinirole (Requip), and a combination of carbidopa and levodopa (Sinemet). However, people with RLS

40 Years Later, Still No Cure  -  Mar 7, 2007
Canton Repository (subscription),Thus I can choose Mirapex or Requip, which serve the same purpose. Today's breakthroughs are quick-acting injectable drugs and delivery by patch rather than

MSU selected as site for national Parkinson’s disease study  -  Mar 23, 2007
MSU Today,To be eligible for the study, one needs a confirmed case of Parkinson’s disease and be on medications that control symptoms, such as Sinemet, Requip or

MSU, UM selected to participate in national Parkinson's disease study  -  Mar 22, 2007
DetNews.com,Eligible patients must have a confirmed case of the disease and take medications such as Sinemet, Requip or Mirapex, for at least nine months but no longer

Anderson Packaging plans to hire 250 in expansion  -  Mar 17, 2007
Rockford Register Star,...allergy relief treatment Claritin, and Dramamine, which treats motion sickness, as well as prescription drugs like Requip, which battles restless leg

New patch can help patients with restless leg syndrome  -  Mar 15, 2007
News 8 Austin,The newest medications of this kind, pramipexole (Mirapex) and ropinirole (Requip), target the motivation, emotion, and reward centers of the brain.

Jerking legs interrupt sleep  -  Feb 22, 2007
Union Sentinel,One new medicine for the treatment of both is Requip. It restores the normal amount of the brain chemical dopamine. The same family of medicines to which

Late-Stage RLS Drug Lands XenoPort $640M GSK Deal  -  Feb 8, 2007
BioWorld Online,The company's dopamine agonist, Requip (ropinirole), was approved as the first drug to treat patients with moderate to severe RLS, a neurological condition

22 Parkinson’s patients on dangerous drug  -  Feb 19, 2007
Malta Today,Patients who spoke to MaltaToday, and who shifted over to alternative drug Requip on their neurologists’ advice, claim to have been paying up to Lm60

Consult a doctor before reading this column  -  Feb 17, 2007
Montrose Daily Press,So my solution: Requip, the first FDA-approved medication for the treatment of RLS. It sounds right until you get to the potential side effects,

Did you know your legs were restless?  -  Jan 31, 2007
MSNBCThe first ads were about symptoms and didn't mention Requip, the drug manufactured by Glaxo that combats RLS. Instead, Glaxo focused on turning RLS into a

Taking quinine for leg cramps  -  Feb 9, 2007
Fort Wayne News Sentinel,Doctors have prescribed drugs such as gabapentin, verapamil, diltiazem, Requip, and muscle relaxants. Supplements have included B-complex vitamins and

'Restless legs' drugs linked to gambling  -  Feb 8, 2007
United Press International8 (UPI) -- Drugs taken for "restless legs syndrome," including Requip (ropinirole) and Mirapex (pramipexole), might be linked to high-roller gambling.

Gambling problem can affect restless legs patients  -  Jan 31, 2007
Scientific AmericanSome of these drugs commonly used for one or both conditions include Requip (generic name ropinirole), Mirapex (pramipexole) and Sinemet (levodopa plus

Compulsive Gambling a possible side-effect of Restless Leg ...  -  Feb 14, 2007
ScienceBlogsIt's trade name is Requip.) Here is the press release:. Compulsive gambling with extreme losses -- in two cases, greater than $100000 -- by people without a

Restless Leg Drug may Cause Compulsive Gambling  -  Feb 12, 2007
Lex 18,The newest medications of this kind, pramipexole (Mirapex) and ropinirole (Requip), target the motivation, emotion, and reward centers of the brain.

GlaxoSmithKline And XenoPort Announce Agreement On Late-stage ...  -  Feb 11, 2007
Medical News Today (press release),If XenoPort decides to co-promote XP13512 in the US, it is also entitled to detail REQUIP products currently in development by GSK, provided they are

Requip, ropinirole treatment for restless legs syndrome  -  Dec 20, 2006
SpiritIndia,Last Super Bowl, a TV commercial lauded the power of Requip (ropinirole), the first drug approved to treat restless leg syndrome, a condition whose

12 Million Can't Sleep, Can't Sit With Restless Legs Syndrome  -  Jan 9, 2007
ABC NewsFor decades, Jefferson has searched to find the right medicine, and when doctors prescribed Requip (ropinirole) — the drug most commonly prescribed for RLS

Heart-Valve Disease Linked to Two Parkinson's Drugs  -  Jan 4, 2007
MedPage Today,Some agents in this class, such as bromocriptine and Dopergine have antagonistic properties, and others, such as Requip and Mirapex have a low affinity for

Ex-teacher battles back from slots addiction  -  Dec 21, 2006
Daily Mail - Charleston,Requip, also known as Ropinirole, and other drugs used to treat Parkinson's have been linked to compulsive gambling. "I was raised in a home without alcohol

Tweaking The Treatment For Restless Legs  -  Dec 26, 2006
Science Daily (press release)Science Daily — Last Super Bowl, a TV commercial lauded the power of Requip (ropinirole), the first drug approved to treat restless leg syndrome,

The worst commercials on television.  -  Dec 26, 2006
SlateThe ad that irks me most at the moment: a spot for the prescription drug Requip. This ad's not so much about the pill itself as about a condition called

Self diagnosis from TV drug ads can be dangerous  -  Jan 8, 2007
Atlanta Journal Constitution (subscription),Kilgore, a 54-year-old attorney, said seeing TV ads touting Requip for Restless Leg Syndrome offered him some psychological comfort about having a medical

Pharma Sector: Few Newsmakers Of The Week - Schwarz Pharma ...  -  Jan 6, 2007
Trading Markets,Analysts expect Glaxo's Requip Modutab, to reach peak sales of $543 million in 2011. CoGenesys will be the next to join the bandwagon of companies marketing

In The Game Of Advertising, Search Is Benched  -  Jan 12, 2007
MediaPost Publications,Neither did I, but Requip treats it. During a search for Restless Legs Syndrome, the product is nowhere to be found–even though the ad has a direct call to

Quick takes on health  -  Jan 10, 2007
Rochester Democrat and Chronicle,Requip (ropinirole) and Mirapex (pramipexole), which are heavily advertised, may seem like simple solutions to the creepy-crawly leg sensations that

Basu: Use more care when prescribing powerful drugs  -  Jan 5, 2007
DesMoinesRegister.com,A related drug called Requip is being widely advertised for the same thing. According to one study in Scotland, 8 percent of Parkinson's patients taking

Parkinson's Patch Nears US Approval  -  Jan 3, 2007
FOX News..."The two currently leading dopamine agonists, Mirapex and Requip, are oral drugs that are shown to do that." Unfortunately, patients on these drugs may

Tweaking The Treatment For Restless Legs  -  26 Dec 2006
Medical News Today (press release),Last Super Bowl, a TV commercial lauded the power of Requip (ropinirole), the first drug approved to treat restless leg syndrome, a condition whose

The worst commercials on television.  -  26 Dec 2006
SlateThe ad that irks me most at the moment: a spot for the prescription drug Requip. This ad's not so much about the pill itself as about a condition called

Ex-teacher battles back from slots addiction  -  Dec 21, 2006
Daily Mail - Charleston,Requip, also known as Ropinirole, and other drugs used to treat Parkinson's have been linked to compulsive gambling. "I was raised in a home without alcohol

You asked, I'll tell: Yes, I do have Parkinson's disease  -  Dec 1, 2006
Belleville News-Democrat,Because I am in a very early stage of the disease, she asked me to join a clinical drug trial and I ended up on a medication known as Requip.

Syndrome affects legs, causes sleep loss  -  Nov 27, 2006
Midland Daily News (subscription),The drug ropinirole (Requip) -- which Burns uses -- has been approved by the FDA for the treatment of moderate to severe restless legs syndrome.

How Glaxo Marketed an Ailment  Oct 24, 2006
Today, the drug, Requip, is on track to post sales of $500 million this year, making it one of the fastest-growing drugs in Glaxo's portfolio. ... -Wall Street Journal (subscription), NovaDel Pharma: Promising New Technology Makes It a Buy  Nov 6, 2006
Requip - Ropinirole spray for Parkinson's disease, currently in pre-clinical characterization. Requip is a trademark of GlaxoSmithKline (GSK). ... -Seeking Alpha, Pushing a disease to sell the drug, report  Oct 26, 2006
The newspaper cited the recent case of GlaxoSmithKline's aggressive marketing campaign for its Parkinson's disease drug Requip to treat an obscure condition ... -United Press International Schwarz drug to top RLS market  Oct 30, 2006
GlaxoSmithKline`s Requip, a Parkinson`s drug that emerged as the market leader for RLS, brought increased attention to the disorder when the Food and Drug ... -Monsters and Critics.com, The Wall Street Journal (subscription required)  Oct 26, 2006
GlaxoSmithKline's Requip should make about $500 million this year--not bad for a drug that treats a syndrome that few people knew existed before the company ... -MediaPost Publications, GlaxoSmithKline: Results Announcement for the Third Quarter 2006  Oct 26, 2006
Sales of Requip, for Parkinson’s disease/Restless Legs Syndrome (RLS), grew significantly in the quarter up 71% to £70 million. ... -PharmaLive.com (press release), Patient groups special: Swallowing the best advice?  Oct 25, 2006
Ingelheim. GSK's drug Requip was approved for the syndrome in 2005, while Boehringer Ingelheim has a drug pending FDA approval. ... -New Scientist (subscription),

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional